Ketamine: A Paradigm Shift for Depression Research and Treatment
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.
Dyck, E. | Journal of psychoactive drugs | 1 March 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Zheng, W., Zhou, Y. L., Liu, W. J., Wang, C. Y., Zhan, Y. N., Li, H. Q., & Ning, Y. P. | Journal of Psychopharmacology | 21 February 2019
Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances
James, E., Robertshaw, T. L., & Westwell, A. D. | Future Medicinal Chemistry | 14 February 2019
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019